<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30664" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tuberculous Meningitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Slane</surname>
            <given-names>Valori H.</given-names>
          </name>
          <aff>Kendall Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Unakal</surname>
            <given-names>Chandrashekhar G.</given-names>
          </name>
          <aff>The University of the West Indies</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Valori Slane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chandrashekhar Unakal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30664.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tuberculous meningitis (TBM) manifests extrapulmonary tuberculosis caused by the seeding of the meninges with the bacilli of <italic toggle="yes">Mycobacterium tuberculosis</italic> (MTB). MTB is first introduced into the host by droplet inhalation infecting the alveolar macrophage. The primary infection localizes in the lung with dissemination to the lymph nodes. At this point in the infectious process, a high degree of bacteremia can seed the entire body. In TBM, the meninges are seeded by MTB and form subependymal collections called Rich foci. These foci can rupture into the subarachnoid space and cause an intense inflammatory response resulting in meningitis symptoms. The exudates caused by this response can encase cranial nerves and cause nerve palsies. They can entrap blood vessels, causing vasculitis, and block cerebral spinal fluid flow, leading to hydrocephalus. These immune responses can lead to complications associated with TBM and chronic sequela in patients who recover from TBM.</p>
        <p>Participants in this course gain critical knowledge on evaluating, managing, and preventing TBM, including the latest public health strategies to combat this global health challenge. The course focuses on enhancing the ability to diagnose TBM early and initiate appropriate treatment swiftly, including managing drug-resistant cases. By emphasizing the importance of interprofessional collaboration, the course demonstrates how coordinated efforts among infectious disease specialists, neurologists, public health professionals, and other healthcare professionals can significantly improve patient outcomes. This collaborative approach is crucial in reducing mortality rates and preventing long-term neurological complications in patients affected by TBM.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate&#x000a0;tuberculosis meningiti from other causes of meningitis using appropriate diagnostic tools, including cerebrospinal fluid analysis and imaging techniques.</p></list-item><list-item><p>Implement current treatment protocols for tuberculosis meningitis, including the management of drug-resistant cases, to optimize patient outcomes.</p></list-item><list-item><p>Apply public health guidelines and preventative measures to reduce the incidence of tuberculosis meningitis in vulnerable populations.</p></list-item><list-item><p>Communicate the importance of improving care coordination among the interprofessional team to enhance care delivery for patients with tuberculous meningitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30664&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30664">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30664.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Mycobacterium tuberculosis </italic>(MTB)&#x000a0;infection in the central nervous system (CNS) may manifest as&#x000a0;meningitis, tuberculoma, and spinal arachnoiditis. Tuberculous meningitis (TBM) is&#x000a0;caused by the seeding of the meninges with the bacilli of MTB&#x000a0;and is&#x000a0;characterized by inflammation of the membranes (meninges) around the brain or spinal cord.&#x000a0;Approximately one-third of the world&#x02019;s population is presumed to be infected with MTB. The number of persons infected with tuberculosis continues to increase despite advances in treatment and worldwide efforts to provide accessibility to medications and standardized treatment protocols.</p>
      </sec>
      <sec id="article-30664.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Predicting which patients with MTB infection will progress to TBM is challenging. Children, particularly those aged 4 and younger, are at higher risk of developing TBM. This condition is more common in the developing world, where MTB infection rates are significantly higher among children. By contrast, in the developed world, TBM is more often seen in adults who experience the reactivation of tuberculosis. Other immunocompromised states like chronic steroid use, diabetes mellitus, and chronic alcoholism carry&#x000a0;a risk of developing TBM.<xref ref-type="bibr" rid="article-30664.r1">[1]</xref> The highest correlation remains with human immunodeficiency virus (HIV) co-infection, with reports that these patients are 5 to 10 times more likely to develop CNS disease.<xref ref-type="bibr" rid="article-30664.r2">[2]</xref></p>
      </sec>
      <sec id="article-30664.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Despite being a preventable and curable disease, tuberculosis is the leading cause of death worldwide due to an infectious etiology; approximately one-third of the world&#x02019;s population is presumed to be infected with MTB. TBM carried a fatal prognosis before the development of antituberculosis medications, and it remains the number&#x000a0;1 cause of death and disability in children infected with MTB.&#x000a0;TBM may also occur during immune reconstitution syndrome that can occur shortly after treatment initiation for HIV with antiretrovirals when undiagnosed MTB infection is present.</p>
        <p>TBM presents in 1% of all cases of extrapulmonary tuberculosis.&#x000a0;In the developed world, where there is a lower prevalence of tuberculosis in the population, estimates are that TBM accounts for 6% of all causes of meningitis. In locations with a higher prevalence of MTB in the population, estimates are that TBM accounts for up to one-third to one-half of all bacterial meningitis.<xref ref-type="bibr" rid="article-30664.r3">[3]</xref>&#x000a0;Those with a concurrent HIV infection have a 5-fold increased risk of having CNS involvement and disseminated tuberculosis, and the risk increases among patients with a CD4 count of less than 100 cells/&#x000b5;L.<xref ref-type="bibr" rid="article-30664.r4">[4]</xref></p>
      </sec>
      <sec id="article-30664.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>MTB is first introduced into the host by droplet inhalation infecting the alveolar macrophage. The primary infection localizes in the lung with dissemination to the lymph nodes. At this point in the infectious process, a high degree of bacteremia can seed the entire body. In TBM, the meninges are seeded by MTB and form subependymal collections called Rich foci. These foci can rupture into the subarachnoid space and cause an intense inflammatory response that causes meningitis symptoms. The exudates caused by this response can encase cranial nerves and cause nerve palsies. They can entrap blood vessels, causing vasculitis, and block cerebral spinal fluid (CSF) flow, leading to hydrocephalus, which may be communicating or non-communicating. These immune responses can lead to complications associated with&#x000a0;TBM and chronic sequela in patients who recover from TBM.<xref ref-type="bibr" rid="article-30664.r5">[5]</xref></p>
        <p>Tuberculous vasculitis leads to constriction, spasm, thrombosis, and occlusion of intracerebral vessels. This ultimately causes&#x000a0;multiple, small, bilateral infarcts, frequently located in the periventricular regions; the basal ganglia, thalamus, and internal capsule are most frequently involved. These infarcts can cause stroke syndromes of the&#x000a0;cerebral cortex, basal ganglia, pons, and/or cerebellum.<xref ref-type="bibr" rid="article-30664.r6">[6]</xref></p>
      </sec>
      <sec id="article-30664.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation of&#x000a0;TBM is similar to other forms of chronic meningitis, making the diagnosis difficult and the differential broad. The clinical presentation is associated with fever, headache, altered sensorium, and focal neurologic deficits. Typical neurologic deficits include facial palsy.<xref ref-type="bibr" rid="article-30664.r2">[2]</xref>&#x000a0;The additional diagnostic difficulty is that the symptoms can be present anywhere from a few days to&#x000a0;6 months. The clinical presentation of TBM is similar regardless of HIV status.<xref ref-type="bibr" rid="article-30664.r1">[1]</xref></p>
        <p>Three distinct phases of clinical presentation are usually found as follows:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>The early prodromal phase is characterized by the insidious onset of low-grade fever, malaise, headache, and personality change&#x02014;usually lasting for&#x000a0;1 to&#x000a0;3 weeks.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The meningitic phase then follows, which is characterized by prominent neurologic features, such as protracted headache, vomiting, meningismus, lethargy, confusion, and varying presentation of cranial nerve and long-tract signs.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Confusion gives way to stupor, seizures, coma, and often hemiparesis in the paralytic phase. Death frequently ensues within&#x000a0;5 to&#x000a0;8 weeks of the onset of untreated illness.<xref ref-type="bibr" rid="article-30664.r7">[7]</xref></p>
          </list-item>
        </list>
        <p>Atypical manifestations&#x000a0;include rapidly progressive meningitic syndrome suggesting pyogenic meningitis, slowly progressive dementia over months, personality change, social withdrawal, memory deficits, and loss of libido. Patients may sometimes also present with an encephalitic course characterized by convulsions, stupor, and coma without overt signs of meningitis.<xref ref-type="bibr" rid="article-30664.r8">[8]</xref></p>
      </sec>
      <sec id="article-30664.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>TBM assessment is&#x000a0;performed by obtaining CSF for analysis, which typically reveals low glucose, elevated protein, and modestly elevated white blood cell count with a lymphocytic predominance. The CSF analysis most closely resembles the CSF analysis of viral meningitis.<xref ref-type="bibr" rid="article-30664.r3">[3]</xref>&#x000a0;Confirming the diagnosis of&#x000a0;TBM&#x000a0;is a difficult diagnostic dilemma; this is especially true in resource-poor areas. Definitive diagnosis results from the identification of MTB in the CSF. Standard Ziehl-Neelsen acid-fast bacilli (AFB) identification smears from CSF are highly unreliable. The positive yield of the AFB smear is broad, with results ranging from 0% to 87%.<xref ref-type="bibr" rid="article-30664.r2">[2]</xref>&#x000a0;CSF mycobacterium cultures vary in yield and are only positive 40% to 83% of the time and can take 6 to 8 weeks to grow.<xref ref-type="bibr" rid="article-30664.r3">[3]</xref>&#x000a0;Over several days, daily large-volume spinal taps sent for microbiological analysis can improve the culture sensitivity by more than 85%.<xref ref-type="bibr" rid="article-30664.r9">[9]</xref>&#x000a0;</p>
        <p>Various new modalities for testing for antigens and antibodies specific to TBM exist using polymerase chain reaction, but they have not won wide acceptance or utilization due to a lack of access to the testing and high variability in the specificity of the test results. The choice of diagnosis in most cases&#x000a0;will&#x000a0;depend on the resources available. Despite advances in developing improved and accurate diagnostic modalities, MTB confirmation by culture in the CSF remains the gold standard.<xref ref-type="bibr" rid="article-30664.r2">[2]</xref><xref ref-type="bibr" rid="article-30664.r3">[3]</xref><xref ref-type="bibr" rid="article-30664.r9">[9]</xref>&#x000a0;Culture allows for the assessment of drug sensitivity results. Drug-resistant MTB carries up to twice the mortality.<xref ref-type="bibr" rid="article-30664.r9">[9]</xref>&#x000a0;Other tests that can be utilized are antigen testing in the urine and adenosine deaminase.<xref ref-type="bibr" rid="article-30664.r10">[10]</xref>&#x000a0;Recent study results have estimated the sensitivity of several diagnostic tests as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ziehl-Neelsen smear (large volume CSF that is centrifuged to concentrate MTB): 34%</p>
          </list-item>
          <list-item>
            <p>GeneXpert: 25%</p>
          </list-item>
          <list-item>
            <p>MTB culture: 32% <xref ref-type="bibr" rid="article-30664.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>CSF lipoarabinomannan: 22%&#x000a0;<xref ref-type="bibr" rid="article-30664.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>GeneXpert Ultra: 44%&#x000a0;<xref ref-type="bibr" rid="article-30664.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>These diagnostic difficulties can lead to&#x000a0;delayed recognition of TBM. They have led to the development of clinical algorithms to&#x000a0;help diagnose TBM and differentiate it from other forms of meningitis. The diagnostic algorithm bases its results on CSF values and patient clinical presentation. The criteria consist of the duration of symptoms 5 or more days, neurologic impairment, CSF to serum blood glucose ratio less than 0.5, and CSF protein level greater than 100 mg/dL. These algorithms have been tested in several retrospective trials and have not received prospective trial validation. Therefore, to diagnose TBM, a high clinical suspicion must remain based on patient risk factors.<xref ref-type="bibr" rid="article-30664.r13">[13]</xref><xref ref-type="bibr" rid="article-30664.r14">[14]</xref></p>
        <p>Neuroimaging can further aid in the diagnosis of TBM. Magnetic resonance imaging (MRI) has demonstrated superiority to computed tomography (CT) scans, as it is of higher quality for assessing the brainstem and spine in detecting TBM.<xref ref-type="bibr" rid="article-30664.r15">[15]</xref> Imaging can assess cerebral infarcts, cerebral edema, and meningeal enhancement. CT imaging is best used to rule out the emergent complication of TBM-related hydrocephalus that can result in the need for immediate neurosurgical intervention.&#x000a0;</p>
      </sec>
      <sec id="article-30664.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Anti-tuberculosis treatment must start promptly to reduce morbidity and mortality in patients with TBM. First-line anti-tuberculosis treatments have excellent CSF penetration (see <bold>Table 1.</bold> First-Line&#x000a0;Drugs for the&#x000a0;Treatment of CNS Tuberculosis). Treatment for TBM consists of&#x000a0;2 months of an intensive phase of daily isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and either streptomycin or ethambutol (EMB).</p>
        <p>This regimen is followed by the continuation phase of 7 to 10 months of INH and RIF. This treatment plan is based on the assumption that the MTB is not a resistant strain. However, drug sensitivity results using standard methods can take months to receive.<xref ref-type="bibr" rid="article-30664.r9">[9]</xref>&#x000a0;The advent of nucleic acid amplification tests has dramatically reduced the time for drug sensitivity testing. In children, EMB is replaced by either an aminoglycoside or ethionamide because of difficulty monitoring for ethambutol-associated optic neuritis (see <bold>Table 2.&#x000a0;</bold>Second-Line&#x000a0;Anti-Tuberculosis&#x000a0;Drugs in&#x000a0;Adults). Treatment with daily RIF, EMB, PZA, and fluoroquinolone is advised with INH-resistant CNS tuberculosis. Moreover, the duration of therapy should be extended to 18 to 24 months, depending on the clinical response to treatment, the severity of the illness, and the patient's immune status.&#x000a0;</p>
        <p>Adjunctive therapy with corticosteroids has been used to treat TBM. There is a limited number of published trials that have assessed the value of adjunctive corticosteroid therapy to treat TBM. A Cochrane Database review concludes that adjunctive corticosteroids provide a mortality benefit but do not reduce rates of neurologic disability.<xref ref-type="bibr" rid="article-30664.r16">[16]</xref> The goal of steroid treatment is to dampen the immune system's exaggerated response, which causes most of the neurologic complications seen with TBM, including tissue damage and brain edema. There has been concern that steroids&#x000a0;can reduce the penetration in the CSF of the anti-tuberculosis medication, but to date, study results have not shown this to occur. While no trials are comparing which steroid is superior, the mainstay treatment has been daily intravenous dexamethasone for up to&#x000a0;4 weeks, followed by a 4-week oral taper.<xref ref-type="bibr" rid="article-30664.r9">[9]</xref></p>
      </sec>
      <sec id="article-30664.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>When evaluating a patient with suspected TBM, it is crucial to consider a broad range of differential diagnoses, as TBM shares symptoms with several other central nervous system conditions. Accurate differentiation between TBM and other forms of meningitis or neurological disorders is essential for timely and appropriate treatment. Conditions that should be considered in the differential diagnosis to ensure a comprehensive evaluation include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial meningitis</p>
          </list-item>
          <list-item>
            <p>Viral meningitis</p>
          </list-item>
          <list-item>
            <p>Encephalitis of all causes</p>
          </list-item>
          <list-item>
            <p>Intracranial space-occupying lesions of various etiologies, including infectious and noninfectious</p>
          </list-item>
          <list-item>
            <p>Nonspecific viral syndromes</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Acute cerebral vascular accident</p>
          </list-item>
          <list-item>
            <p>A sympathomimetic syndrome due to drug abuse</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30664.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>TBM is considered the deadliest form of MTB infection.<xref ref-type="bibr" rid="article-30664.r17">[17]</xref>&#x000a0;TBM carries a mortality rate between 20% and 67% with anti-tuberculosis treatment and is fatal without treatment.<xref ref-type="bibr" rid="article-30664.r3">[3]</xref>&#x000a0;Patients at the extremes&#x000a0;of age and patients with HIV co-infection carry the highest mortality.<xref ref-type="bibr" rid="article-30664.r17">[17]</xref><xref ref-type="bibr" rid="article-30664.r18">[18]</xref>&#x000a0;The prognosis of TBM depends on the patient's neurologic status at the time of initial presentation and the timeliness of the initiation of anti-tuberculous agents.<xref ref-type="bibr" rid="article-30664.r2">[2]</xref>&#x000a0;Patients who develop hydrocephalus secondary to MTB also have a poor prognosis, even with neurosurgical intervention.<xref ref-type="bibr" rid="article-30664.r9">[9]</xref><xref ref-type="bibr" rid="article-30664.r18">[18]</xref></p>
      </sec>
      <sec id="article-30664.s11" sec-type="Complications">
        <title>Complications</title>
        <p>TBM can cause a myriad of neurologic sequela that can be present at initial presentation and can produce residual effects even after successful treatment.<xref ref-type="bibr" rid="article-30664.r19">[19]</xref>&#x000a0;Complications&#x000a0;include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hydrocephalus due to obstruction of CSF outflow causes&#x000a0;raised intracranial pressure.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion is seen in 40% to 50% of patients with TBM.<xref ref-type="bibr" rid="article-30664.r20">[20]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tuberculomas can occur independently of TBM.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Vasculitis and stroke occur in 15% to 57% of patients with TBM, depending on which diagnostic modalities are used in diagnosis, with MRI being diagnostically superior in diagnosis to CT.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Seizures, generally focal, result from&#x000a0;hyponatremia,&#x000a0;infarction, and&#x000a0;meningeal irritation.<xref ref-type="bibr" rid="article-30664.r21">[21]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Loss of vision that could be permanent due to compression of the optic chiasma by&#x000a0;a dilated third ventricle or as a result of optic nerve compression due to thick tuberculous exudates.<xref ref-type="bibr" rid="article-30664.r22">[22]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Transverse myelitis manifests as&#x000a0;paraparesis or quadriparesis, sensory symptoms, and urinary retention in the lower limbs.<xref ref-type="bibr" rid="article-30664.r23">[23]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30664.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients with TBM require a multidisciplinary approach involving consultations with various specialists to ensure comprehensive care. A neurologist is essential for managing neurological symptoms and monitoring the progression of the disease. Infectious disease specialists play a crucial role in guiding the use of anti-tuberculosis medications and addressing potential drug-resistant strains. A pulmonologist may be consulted if the patient has concurrent pulmonary tuberculosis. Additionally, a neuro-radiologist should be involved in advanced imaging interpretation, which is crucial for diagnosis and monitoring. In cases with complications or surgical indications, a neurosurgeon might be required. Collaborative input from these clinicians enhances patient outcomes by addressing the multifaceted challenges of TBM.</p>
      </sec>
      <sec id="article-30664.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence and patient education are vital components in managing and preventing TBM. Educating patients, especially those in high-risk populations, about the importance of early detection is essential.&#x000a0;The primary goal in&#x000a0;tuberculosis treatment of all forms involves medication regimen adherence. Treatment of all varieties of tuberculosis is lengthy, and without strict adherence, resistance develops, creating a considerable public health risk. Adherence to tuberculosis treatment can significantly reduce the incidence of TBM.</p>
        <p>Healthcare professionals should emphasize the need for complete and consistent treatment of MTB&#x000a0;infection to prevent the progression to TBM. Additionally, educating patients and communities about the signs and symptoms of TBM, the importance of prompt medical evaluation, and the risks associated with delayed treatment can improve outcomes. Public health efforts focused on vaccination, particularly with the bacille Calmette-Gu&#x000e9;rin&#x000a0;vaccine in endemic areas, and promoting awareness can further contribute to reducing the burden of TBM.</p>
      </sec>
      <sec id="article-30664.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>MTB eradication is a top priority in global health. Healthcare professionals across all disciplines are vital to the continued progress of this&#x000a0;massive effort. Worldwide, eradication efforts have involved every aspect of society. Collaboration between frontline clinicians and government health entities will significantly improve the outcomes of these efforts. Public and private sector contributions are imperative to advancing MTB diagnostic modalities and treatments.<xref ref-type="bibr" rid="article-30664.r24">[24]</xref></p>
        <p>Effectively managing individual TBM cases requires an&#x000a0;interprofessional approach that emphasizes patient-centered care, optimal outcomes, and team performance. Each healthcare professional plays a critical role in this collaborative effort. Clinicians should be adept at recognizing early symptoms, selecting appropriate diagnostic tests, and devising comprehensive treatment plans. Nurses, often the frontline caregivers, must skillfully monitor patient status, manage symptoms, and provide education on medication adherence. Pharmacists ensure the correct administration of anti-tuberculosis drugs, manage drug interactions, and counsel patients on potential&#x000a0;adverse&#x000a0;effects.</p>
        <p>The clinical strategy should be coordinated and aligned with evidence-based practices to ensure timely and effective interventions.&#x000a0;Successful&#x000a0;care coordination is vital to managing patients with TBM, particularly given the complexity of treatment regimens and the potential for complications.&#x000a0;The ultimate goal of this collaborative effort is to enhance patient-centered care and improve outcomes. By working together, healthcare professionals can ensure that care is tailored to the individual needs of each patient, addressing not only their medical condition but also their emotional, social, and cultural needs. This team-based approach helps to reduce the risk of complications, improve treatment adherence, and ultimately enhance the quality of life for patients with TBM.</p>
      </sec>
      <sec id="article-30664.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30664&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30664">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/tuberculous-meningitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30664">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30664/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30664">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30664.s16">
        <title>References</title>
        <ref id="article-30664.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chin</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: Diagnostic and therapeutic challenges.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-205</page-range>
            <pub-id pub-id-type="pmid">25110618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soria</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Metcalf</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Newby</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Montano</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Huaroto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ticona</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zunt</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Mortality in hospitalized patients with tuberculous meningitis.</article-title>
            <source>BMC Infect Dis</source>
            <year>2019</year>
            <month>Jan</month>
            <day>05</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">30611205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>A New Scoring System for the Differential Diagnosis between Tuberculous Meningitis and Viral Meningitis.</article-title>
            <source>J Korean Med Sci</source>
            <year>2018</year>
            <month>Jul</month>
            <day>30</day>
            <volume>33</volume>
            <issue>31</issue>
            <fpage>e201</fpage>
            <pub-id pub-id-type="pmid">30069169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourgi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fiske</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis Meningitis.</article-title>
            <source>Curr Infect Dis Rep</source>
            <year>2017</year>
            <month>Sep</month>
            <day>11</day>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">28895024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaites</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Drobniewski</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>McAdam</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>289</fpage>
            <page-range>289-99</page-range>
            <pub-id pub-id-type="pmid">10675209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mak</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Cerebral infarcts complicating tuberculous meningitis.</article-title>
            <source>Cerebrovasc Dis</source>
            <year>2005</year>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>391</fpage>
            <page-range>391-5</page-range>
            <pub-id pub-id-type="pmid">15863982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farinha</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Razali</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Holzel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Novelli</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis of the central nervous system in children: a 20-year survey.</article-title>
            <source>J Infect</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-8</page-range>
            <pub-id pub-id-type="pmid">10942642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Udani</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Dastur</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations.</article-title>
            <source>J Neurol Sci</source>
            <year>1970</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>541</fpage>
            <page-range>541-61</page-range>
            <pub-id pub-id-type="pmid">5422557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marx</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: diagnosis and treatment overview.</article-title>
            <source>Tuberc Res Treat</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>798764</fpage>
            <pub-id pub-id-type="pmid">22567269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>LoBue</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Loeffler</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mazurek</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richeldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salfinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shinnick</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Warshauer</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Jan</month>
            <day>15</day>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-115</page-range>
            <pub-id pub-id-type="pmid">28052967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heemskerk</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Donovan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thu</surname>
                <given-names>DDA</given-names>
              </name>
              <name>
                <surname>Marais</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaidir</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dung</surname>
                <given-names>VTM</given-names>
              </name>
              <name>
                <surname>Centner</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>VTN</given-names>
              </name>
              <name>
                <surname>Annisa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bovijn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>NTH</given-names>
              </name>
              <name>
                <surname>Phu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>NVV</given-names>
              </name>
              <name>
                <surname>Ganiem</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Van</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Geskus</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Thuong</surname>
                <given-names>NTT</given-names>
              </name>
              <name>
                <surname>Ruslami</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meintjes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van Crevel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl-Neelsen stain, GeneXpert, and culture of cerebrospinal fluid.</article-title>
            <source>J Infect</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>509</fpage>
            <page-range>509-515</page-range>
            <pub-id pub-id-type="pmid">30217659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donovan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Huynh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: where to from here?</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-266</page-range>
            <pub-id pub-id-type="pmid">32324614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jipa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Olaru</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Manea</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Merisor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hristea</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Rapid Clinical Score for the Diagnosis of Tuberculous Meningitis: A Retrospective Cohort Study.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>363</fpage>
            <page-range>363-366</page-range>
            <pub-id pub-id-type="pmid">29184338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hristea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olaru</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Baicus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moroti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arama</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ion</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical prediction rule for differentiating tuberculous from viral meningitis.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>793</fpage>
            <page-range>793-8</page-range>
            <pub-id pub-id-type="pmid">22507645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shuai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Quan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>MRI advances in the imaging diagnosis of tuberculous meningitis: opportunities and innovations.</article-title>
            <source>Front Microbiol</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1308149</fpage>
            <pub-id pub-id-type="pmid">38149270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prasad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids for managing tuberculous meningitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Apr</month>
            <day>28</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD002244</fpage>
            <pub-id pub-id-type="pmid">27121755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meintjes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Tuberculous Meningitis and Its Complications in Adults.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2018</year>
            <month>Feb</month>
            <day>28</day>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">29492737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in northern Taiwan.</article-title>
            <source>J Microbiol Immunol Infect</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-8</page-range>
            <pub-id pub-id-type="pmid">20457427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis diagnosis and treatment in adults: A series of 189 suspected cases.</article-title>
            <source>Exp Ther Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>2770</fpage>
            <page-range>2770-2776</page-range>
            <pub-id pub-id-type="pmid">30210618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Kalita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bhoi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>A study of hyponatremia in tuberculous meningitis.</article-title>
            <source>J Neurol Sci</source>
            <year>2016</year>
            <month>Aug</month>
            <day>15</day>
            <volume>367</volume>
            <fpage>152</fpage>
            <page-range>152-7</page-range>
            <pub-id pub-id-type="pmid">27423581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kalita</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Seizures in tuberculous meningitis.</article-title>
            <source>Epilepsy Res</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>148</volume>
            <fpage>90</fpage>
            <page-range>90-95</page-range>
            <pub-id pub-id-type="pmid">30396007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Uniyal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Vision loss in tuberculous meningitis.</article-title>
            <source>J Neurol Sci</source>
            <year>2017</year>
            <month>Apr</month>
            <day>15</day>
            <volume>375</volume>
            <fpage>27</fpage>
            <page-range>27-34</page-range>
            <pub-id pub-id-type="pmid">28320145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Suo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome.</article-title>
            <source>Front Neurol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>830029</fpage>
            <pub-id pub-id-type="pmid">35370906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30664.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silva</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Rendon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alffenaar</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Chakaya</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Global TB Network: working together to eliminate tuberculosis.</article-title>
            <source>J Bras Pneumol</source>
            <year>2018</year>
            <season>Set-Oct</season>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>347</fpage>
            <page-range>347-349</page-range>
            <pub-id pub-id-type="pmid">30304206</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
